There’s a moment in the life of any new category when the question stops being “is there a need?” and starts being “who’s accountable when it scales?”
The AI companion market is at that moment now.
In 2025 alone, 128 new companion applications launched. Today there are 337 active, revenue-generating products in the category globally. Combined revenue crossed $20 million in April 2026. And in March, UnitedHealthcare – the largest health insurer in the United States – announced it was rolling out an AI companion to its 20.5 million members.
This is no longer a niche. It’s infrastructure.
From Hobby App to Health System
UnitedHealthcare’s entry is the clearest signal yet that the category is moving into institutional territory. A healthcare giant doesn’t distribute a new product to twenty million people without running the numbers. Something in the equation – cost, outcomes, engagement, potential – pointed the right way.
That’s significant for more than one reason.
It confirms that scalable AI companionship is being treated as a serious tool in healthcare contexts. And it sets a new benchmark for what the category is expected to deliver – and what happens when it falls short.
Healthcare is a context with sharp accountability. When a product is distributed through an insurance company, under a framework of health services, the expectations around design, safety, and outcomes change fundamentally. It’s not the same as downloading an app from the App Store by personal choice.
Growth Doesn’t Solve the Design Problem
128 new apps in a single year isn’t a sign of a mature market. It’s a sign that the barrier to entry is low and the space is still taking shape.
It’s also not a coincidence that Character.AI is reporting 233 million registered users in the same period that the first legal settlement following a teenager’s suicide was reached. Or that five US states passed or advanced legislation regulating this category of services in the first quarter of this year alone.
The category is growing and being regulated at the same time. That’s not a contradiction – it’s the normal trajectory for a technology that touches enough people deeply enough that social institutions have to respond.
For the products that actually want to exist long-term, the question isn’t how to avoid regulation. It’s how to build something that holds up under scrutiny.
Scale Pushes Toward the Same Mistakes
There’s an economic logic in this category worth examining carefully.
A companion app with strong engagement metrics looks like a success on paper: high return rate, long sessions, deep emotional investment from the user. That’s what investors measure. That’s what growth models reward.
It’s also exactly what drives dependency.
Scale doesn’t make that dynamic safer. It makes it wider. The more users there are, the more of them will end up in the pattern Drexel University recently documented – a relationship that started as helpful and gradually became an anchor.
A category that sells connection but profits from isolation has a structural problem. And that problem doesn’t disappear because the product is now distributed through one of the country’s largest health insurers.
What Mainstream Actually Demands
Mainstream isn’t just a measure of reach. It’s a measure of responsibility.
When a technology reaches twenty million health insurance members, an entire generation of teenagers, and hundreds of millions of registered users, the definition of good design starts to change. It’s no longer enough to build something that feels good in a demo or ranks well in the App Store. It needs to work – and not cause harm – across a wide range of human situations, needs, and levels of vulnerability.
That’s a different set of requirements. And it’s not optional.
Prinsessa is built with that list in mind. Not as a response to regulatory pressure, but as a fundamental choice about what companionship should actually be. Our mission isn’t about being the fastest-growing app in the category. It’s about being the right one.
In a market with 337 products and a healthcare giant with 20 million members, that difference matters.
Sources: Roborhythms AI Companion Market Breakdown, April 2026.
